← Leaderboards
Adam A Rosenberg
University Of Colorado Denver
$1,227,072
Attributed
$1,227,072
Total exposure
10
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $162.9K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$1,227,072 · 10
By mechanism
P50$702,558 · 1
M01$524,514 · 9
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Donald Ym Leung$75,548,590
- Colleen Glyde Julian$3,623,041
- Emily L Dobyns$747,203
- Ethan P. Carter$734,502
- John P Kinsella$11,583,028
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman Therapy EvaluationHuman SubjectNewborn Human (0-6 Weeks)Pulmonary HypertensionNitric OxideInhalation Drug AdministrationLongitudinal Human StudyPremature Infant HumanPatient Oriented ResearchOxidative StressAtrial Natriuretic PeptidePathologic ProcessClinical TrialsVasodilationPulmonary SurfactantsBiomedical FacilityRespiratory Distress Syndrome Of NewbornRespiratory Insufficiency /FailureLow Birth Weight Infant HumanInfantInfant, PrematureHeart TransplantationErythropoietin
Grant awards (15)
ASSESSMENT OF THE SAFETY AND EFFICACY OF DARBEPOIETIN ALFA IN PRETERM INFANTS$70,314
M01 · FY2007 · RR · contact PI
LONG TERM FOLLOW-UP OF CARDIAC TRANSPLANT PATIENTS$43,923
M01 · FY2007 · RR · contact PI
LONG TERM FOLLOW-UP OF CARDIAC TRANSPLANT PATIENTS$111,986
M01 · FY2006 · RR · contact PI
LONG TERM FOLLOW-UP OF CARDIAC TRANSPLANT PATIENTS$142,439
M01 · FY2005 · RR
USE OF INTRAVENOUS STAPH AUREUS IMMUNE GLOBULIN IN VLBW NEONATES$20,510
M01 · FY2005 · RR
Long Term Follow-up of Cardiac Transplant Patients$91,462
M01 · FY2004 · RR
Hi-Dose "Rescue" Erythropoietin Therapy on Anemic Infant$14,572
M01 · FY2004 · RR
Intravenous S. aureus Immune Globulin in VLBW Neonates$7,827
M01 · FY2004 · RR
Brain-Cooling Tx of Perinatal Hypoxic-Ischemic Encephal.$1,621
M01 · FY2004 · RR
CORE--CLINICAL CORE$208,827
P50 · FY2002 · HL
NITRIC OXIDE TRIALS$0
M01 · FY2002 · RR
CORE--CLINICAL CORE$208,827
P50 · FY2001 · HL
CORE--CLINICAL CORE$284,904
P50 · FY2000 · HL
CLINICAL EVALUATION OF STERILE CAFFEINE CITRATE IN TREATMENT--APNEA PREMATURITY$19,860
M01 · FY2000 · RR
NITRIC OXIDE TRIALS$0
M01 · FY2000 · RR